Pharmaceutical Continuous Manufacturing: Regulatory landscape in the spotlight at USP workshop
Quality Matters
SEPTEMBER 15, 2023
FDA representatives emphasized the agency’s commitment to working with industry to mitigate potential regulatory hurdles to PCM adoption during USP’s workshop on “ Identifying and Addressing Barriers to Continuous Manufacturing Adoption ” July 18-19 in Rockville, Maryland. It is not intended as a comprehensive summary or report.
52 
Let's personalize your content